🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alexandra Dreyzin

National Institutes of Health

ORCID: 0000-0003-1414-290X

Also affiliated with Foundation for the National Institutes of Health, National Cancer Institute, Center for Cancer Research, National Institutes of Health Clinical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL”.

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

Blood Advances(2023)10.1182/bloodadvances.2022008893
N/A
0.515DataRank · unranked
30 citations

Stephanie J. Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J. Chen +28 more

Ten-year experience of CD22 CAR T cells for children and young adults with B-cell acute lymphoblastic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025017753
N/A
0.241DataRank · unranked
4 citations

Bonnie Yates, Haneen Shalabi, Sara Silbert, Hao‐Wei Wang, Constance M. Yuan +13 more

Physical and emotional quality of life in children with B-acute lymphoblastic leukemia randomized to every 4- vs. 12-week vincristine/dexamethasone during maintenance: Children’s Oncology Group AALL0932.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10025
N/A
0.104DataRank · unranked
1 citations

John A. Kairalla, Emily Hibbitts, Rozalyn L. Rodwin, Meenakshi Devidas, Alexandra Dreyzin +10 more

Deciphering the importance of culture pH on CD22 CAR T-cells characteristics

Journal of Translational Medicine(2024)10.1186/s12967-024-05197-5
N/A
0DataRank · unranked
7 citations

Alexandra Dreyzin, Lipei Shao, P Arazo Garcés, Yihua Cai, Rongye Shi +15 more

Immunophenotype of CAR T cells and apheresis products predicts response in CD22 CAR T cell trial for B cell acute lymphoblastic leukemia

Molecular Therapy(2025)10.1016/j.ymthe.2025.03.019
N/A
0DataRank · unranked
14 citations

Lipei Shao, Yihua Cai, Kyu Lee Han, Michaela Prochazkova, Michael Gertz +11 more

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML

Blood Advances(2025)10.1182/bloodadvances.2025017011
N/A
0DataRank · unranked
7 citations

Richard Aplenc, Susanne H.C. Baumeister, Marco Becilli, Anand Bhagwat, Challice L. Bonifant +30 more

CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia

British Journal of Haematology(2025)10.1111/bjh.70019
N/A
0DataRank · unranked
5 citations

Noa G. Holtzman, Challice L. Bonifant, Alexandra Dreyzin

Diminished Quality of Life Despite Reduced Treatment in Children with B-Lymphoblastic Leukemia: Children’s Oncology Group AALL0932

PubMed Central(2025)10.22541/au.175344126.66272705/v1
N/A
0DataRank · unranked
0 citations

John A. Kairalla, Emily Hibbitts, Rozalyn L. Rodwin, Meenakshi Devidas, Alexandra Dreyzin +10 more

Caregivers’ Perspectives on Changes in Family Life During B‐ALL Therapy: A Qualitative Study From the Children's Oncology Group

Pediatric Blood & Cancer(2025)10.1002/pbc.32057
N/A
0DataRank · unranked
0 citations

Megan E. Ware, Katrina Stumbras, John A. Kairalla, Emily Hibbitts, Brenna Mossman +13 more

Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.12.004
N/A
0DataRank · unranked
17 citations

Sandhya R. Panch, Haneen Shalabi, Bonnie Yates, Steven L. Highfill, Ping Jin +3 more

Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies

Cytotherapy(2025)10.1016/j.jcyt.2025.09.013
N/A
0DataRank · unranked
0 citations

Anne Marijn Kramer, Bonnie Yates, Hao‐Wei Wang, Bita Sahaf, Constance M. Yuan +28 more

Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapy

Cytotherapy(2024)10.1016/j.jcyt.2024.11.013
N/A
0DataRank · unranked
11 citations

Isabella Vignola, Sarmila Sarkar, Michaela Prochazkova, Yihua Cai, Rongye Shi +12 more

Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy

Expert Review of Clinical Immunology(2024)10.1080/1744666x.2024.2349738
N/A
0DataRank · unranked
12 citations

Alexander W. Rankin, Katia Luciani, Tatyana Gavrilova, Nirali N. Shah, Alexandra Dreyzin